A substantial insider activity was disclosed on January 12, as Lippoldt, Chief Legal Officer at Neurocrine Biosciences (NASDAQ:NBIX), reported the exercise of a large sell of company stock options. What Happened: Lippoldt, Chief Legal Officer at Neurocrine Biosciences, exercised stock options for…
Continue reading...